40
Participants
Start Date
December 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
UC-MSC
0.25ml Shanghai Life UC-MSC injection is resuspended into 10ml of cell suspension and slowly infused into infarct-related blood vessels through an administration catheter in 2 minutes, and the number of cells transplanted each time is 5x10(6) cells. The UC-MSC products are manufactured by Shanghai Life with viability\>80%, and endotoxin\<0.1 EU, at the concentration of 2x10(7) cells/ml.
Control Group
Routine treatment without catheter infusion
Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
OTHER
Shanghai Life Science & Technology
INDUSTRY